CNTA vs ECL · $6.15B cap vs P/E 35, rev $4.01B
Centessa Pharmaceuticals PLC ADR (CNTA) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported CNTA revenue for 2024-12-31 was $0. Net income was -$235.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CNTA currently screens at market cap $6.15B.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
CNTA currently screens at market cap $6.15B. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the CNTA and ECL stock pages for the full models.
Not investment advice.